Cleared Abbreviated

InBody (K200442) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through the Abbreviated 510(k) pathway - typically does not require clinical trials.

K200442 · Inbody Co., Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2020
Decision
284d
Days
Class 2
Risk

K200442 is an FDA 510(k) clearance for the InBody. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Inbody Co., Ltd. (Seoul, KR). The FDA issued a Cleared decision on December 4, 2020 after a review of 284 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Inbody Co., Ltd. devices

Submission Details

510(k) Number K200442 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 24, 2020
Decision Date December 04, 2020
Days to Decision 284 days
Submission Type Abbreviated
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
159d slower than avg
Panel avg: 125d · This submission: 284d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Kamm & Associates
Daniel Kamm

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 269
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K200442.
Upper Arm Electronic Blood Pressure Monitor
K202372 · Conmo Electronic Company Limited · Dec 2020
Wrist Type Blood Pressure Monitor
K200346 · Avita Corporation · Dec 2020
Transtek Wrist Blood Pressure Monitor
K202599 · Guangdong Transtek Medical Electronics Co., Ltd. · Dec 2020
Electronic Blood Pressure Monitor
K200716 · Shenzhen Pango Electronic Co., Ltd. · Dec 2020
V20, V20a, AVSM3 SNF
K200434 · Mediana Co., Ltd. · Oct 2020
Blood Pressure Monitor-Model 2005, 2006-2, 2006-2B
K201467 · Bioland Technology, Ltd. · Sep 2020